Specialists at an FDA public workshop cautioned on Thursday that key questions about testosterone therapy’s long-term safety remain unanswered.
FDA examines use of testosterone prescriptions for menopause
Specialists at an FDA public workshop cautioned on Thursday that key questions about testosterone therapy’s long-term safety remain unanswered.
Sign in to your account